Using MRI for the assessment of paraoxon-induced brain damage and efficacy of antidotal treatment.
Rosman Y, Eisenkraft A, Krivoy A, Schein O, Makarovski I, Shrot S, Ramaty E, Shilderman EB, Kapon J, Gilat E, Kadar T, Maier S, Daniels D, Shneor R, Salomon S, Tamar G, Last D, Mardor Y.
Rosman Y, et al. Among authors: eisenkraft a.
J Appl Toxicol. 2012 Jun;32(6):409-16. doi: 10.1002/jat.1715. Epub 2011 Aug 22.
J Appl Toxicol. 2012.
PMID: 21861267